Validation of an artificial intelligence-based drawing platform against the Clock Drawing Test for cognitive screening: a comparative study between Alzheimer's disease and healthy controls
Family Practice · 2026
DOI: 10.1093/fampra/cmag066 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Family Practice, 2026. Verfasst von Ülkü Sur Ünal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Marmara University School of Medicine, Istanbul 34854, Türkiye. Hauptthemen laut MEDLINE: Alzheimer Disease, Artificial Intelligence, Neuropsychological Tests. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Traditional manual Clock Drawing Tests (CDTs) are widely used for cognitive screening but are constrained by human subjectivity and alphanumeric literacy or cultural barriers.
Objective
This study validated an open-source artificial intelligence (AI)-based drawing platform utilizing universal, pre-linguistic Lea symbols against manual CDT metrics for cognitive screening and differentiating Alzheimer's disease (AD) from healthy controls (HCs).
Methods
In this cross-sectional validation study, 111 participants aged ≥65 years, 55 clinically diagnosed AD patients and 56 HCs, were evaluated. Participants completed manual CDTs (6-point and 10-point scoring) and the AI-based drawing task on a tablet. Diagnostic accuracy was evaluated using receiver operating characteristic curve analysis, Cohen's kappa (κ), and multivariable logistic regression adjusted for age and gender.
Results
The AI model demonstrated clear diagnostic accuracy (area under the curve = 0.868), with overall accuracy comparable to the 10-point manual scale. An optimal diagnostic cut-off of <27.00 points, identified in this study, achieved 83.6% sensitivity and 75.0% specificity, demonstrating substantial agreement with clinical diagnosis (κ = 0.586, P < 0.001). Crucially, the AI-based drawing platform flagged 14 HCs (25.0%) as at-risk who were classified as intact by conventional manual CDT scales. Multivariable regression confirmed the AI score as a powerful independent predictor of AD status after adjusting for demographics (odds ratio: 0.940, 95% confidence interval: 0.904–0.979, P < 0.001).
Conclusion
The AI-based drawing platform provides an objective, automated alternative to traditional CDTs. Its sensitivity to subtle visuoconstructional variations positions it as an effective, low-cost triage tool to optimize early neurological referrals in primary care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine, Marmara University School of Medicine, Istanbul 34854, Türkiye.
- Marmara University School of Medicine, Istanbul 34854, Türkiye.
ORCID-Profile: Ülkü Sur Ünal
Zitieren
APA
Sur Ünal, Ü., Karabaş, H. A., Yadigar, A., Turnalı, A. S., & Demir, E. (2026). Validation of an artificial intelligence-based drawing platform against the Clock Drawing Test for cognitive screening: a comparative study between Alzheimer's disease and healthy controls. Family Practice. https://doi.org/10.1093/fampra/cmag066
Vancouver
Sur Ünal Ü, Karabaş HA, Yadigar A, Turnalı AS, Demir E. Validation of an artificial intelligence-based drawing platform against the Clock Drawing Test for cognitive screening: a comparative study between Alzheimer's disease and healthy controls. Family Practice. 2026. doi:10.1093/fampra/cmag066
BibTeX
@article{Surnal2026,
author = {Sur Ünal, Ülkü and Karabaş, Halil Alper and Yadigar, Aybora and Turnalı, Ahsen Simanur and Demir, Elifnur},
title = {Validation of an artificial intelligence-based drawing platform against the Clock Drawing Test for cognitive screening: a comparative study between Alzheimer's disease and healthy controls},
journal = {Family Practice},
year = {2026},
doi = {10.1093/fampra/cmag066}
}
EUVIMED